Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Fierce biotech summit 2024

    1 min read

    Fierce Biotech Summit 2024

    Meet Veristat in Boston at the Fierce Biotech Summit Conference | September 30 - October 1 in Boston, Massachusetts

    We are delighted to announce Veristat's participation in the upcoming Fierce Biotech Summit. This is an excellent opportunity to connect with our team of seasoned experts in clinical development, regulatory affairs, and biometrics. Our professionals are dedicated to guiding your innovative therapies through the complex landscape of drug development and regulatory approval.

    Veristat supports successful clinical trials and regulatory submissions across a wide range of therapeutic areas, including rare diseases, oncology, and complex clinical development programs. Our expertise spans: 

    • Strategic clinical trial design and execution
    • Comprehensive regulatory strategy and submissions
    • Advanced biostatistics and data management
    • Medical writing and regulatory publishing

    Overcome the challenges of drug development with confidence. Let Veristat's proven track record of 160+ marketing applications and 80+ regulatory approvals work for you. Connect with us at the Fierce Biotech Summit to learn how we can accelerate your path to approval and bring your innovations to patients faster. 

     

    Schedule A Meeting

    Veristat team member, Erin Gaffney, Senior Business Development Director, will be at the venue, ready to listen to your needs and share more about Veristat’s expertise.  Arrange a meeting today!  Complete the form on the right side of this page and we will confirm the date and time. 

    Conference Details

    Website: Fierce Biotech Summit

     

     

     

     

     

     

     

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...